Dissolution testing

Drug Dissolution Testing is regularly done to characterize and give information regarding the in vitro drug release for Q.C check and the development of the drug.
By using IVIVC techniques, the in vitro drug dissolution data obtained from dissolution testing experiments may be interrelated to in vivo pharmacokinetic data. An entrenched analytical IVIVC model is very helpful for the drug formulation design and constructive changes in the post-approval. In-vitro Dissolution test is a crucial test that has to associate with in-vivo clinical study and could necessitate definite process progress.

OMICS Group Conferences are assimilated with poster presentations, B2B meetings, Scientific Partnering, panel discussions, symposium, sponsoring, exhibiting, and workshops by gathering people on a solitary podium thereby attaining its slogan of expanding and disseminate the knowledge across the globe in various fields. In B2B meetings, delegates have the chance to congregate with the researchers, entrepreneurs, directors, and managers from all over the world to discuss potential business partnerships. Biosimilars-2014 B2B sessions, managed by ConferenceSeries International Conferences, facilitate members to identify business opportunities. B2B Sales Meetings imparts high-level engagement setting and demand generation services for business-to-business technology companies. Companies are making agreements with each other in an attempt to construct on common synergies in a fast globalizing world.

Conferences:
ECA - Dissolution Testing
Conference on Dissolution, Bioequivalence and Bioavailability
Conference on In Vitro Release and Dissolution Testing
Bioavailability - Bioequivalence, Dissolution testing and Biowaivers

Associations:
Royal Pharmaceutical Society
American Association of Pharmaceutical Scientists

This page will be updated regularly.

This page was last updated on April 24, 2024